Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 2754756, 12 pages
https://doi.org/10.1155/2017/2754756
Research Article

Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21

1Department of Biomedical & Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA
2Vascular Biology Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA
3Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
4David Geffen UCLA School of Medicine and UCLA Jonson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA

Correspondence should be addressed to Mei-Zhen Cui; ude.ktu@miuc and Xuemin Xu; ude.ktu@xmx

Received 19 November 2016; Accepted 18 January 2017; Published 19 February 2017

Academic Editor: Anshu Agrawal

Copyright © 2017 Yunzhou Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Hosogaya, Y. Yatomi, K. Nakamura et al., “Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity,” Annals of Clinical Biochemistry, vol. 45, no. 4, pp. 364–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Gardell, A. E. Dubin, and J. Chun, “Emerging medicinal roles for lysophospholipid signaling,” Trends in Molecular Medicine, vol. 12, no. 2, pp. 65–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Ye, I. Ishii, M. A. Kingsbury, and J. Chun, “Lysophosphatidic acid as a novel cell survival/apoptotic factor,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1585, no. 2-3, pp. 108–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. G. Bourgoin and C. Zhao, “Autotaxin and lysophospholipids in rheumatoid arthritis,” Current Opinion in Investigational Drugs, vol. 11, no. 5, pp. 515–526, 2010. View at Google Scholar · View at Scopus
  5. Y. Zhao and V. Natarajan, “Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling,” Biochimica et Biophysica Acta, vol. 1831, no. 1, pp. 86–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Tigyi, “Aiming drug discovery at lysophosphatidic acid targets,” British Journal of Pharmacology, vol. 161, no. 2, pp. 241–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. van Corven, A. Groenink, K. Jalink, T. Eichholtz, and W. H. Moolenaar, “Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins,” Cell, vol. 59, no. 1, pp. 45–54, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Moolenaar, L. A. Van Meeteren, and B. N. G. Giepmans, “The ins and outs of lysophosphatidic acid signaling,” BioEssays, vol. 26, no. 8, pp. 870–881, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. W. H. Moolenaar, “Bioactive lysophospholipids and their G protein-coupled receptors,” Experimental Cell Research, vol. 253, no. 1, pp. 230–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Kranenburg and W. H. Moolenaar, “Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists,” Oncogene, vol. 20, no. 13, pp. 1540–1546, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Du, C. Sun, Z. Hu et al., “Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling,” PLoS ONE, vol. 5, no. 12, Article ID e15940, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Boucharaba, C.-M. Serre, S. Grès et al., “Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer,” The Journal of Clinical Investigation, vol. 114, no. 12, pp. 1714–1725, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Boucharaba, C.-M. Serre, J. Guglielmi, J.-C. Bordet, P. Clézardin, and O. Peyruchaud, “The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 25, pp. 9643–9648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Yamada, K. Sato, M. Komachi et al., “Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6595–6605, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Fang, D. Gaudette, T. Furui et al., “Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer,” Annals of the New York Academy of Sciences, vol. 905, pp. 188–208, 2000. View at Google Scholar · View at Scopus
  16. J. W. Choi, D. R. Herr, K. Noguchi et al., “LPA receptors: subtypes and biological actions,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 157–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Steiner, F. W. Holtsberg, J. N. Keller, M. P. Mattson, and S. M. Steiner, “Lysophosphatidic acid induction of neuronal apoptosis and necrosis,” Annals of the New York Academy of Sciences, vol. 905, pp. 132–141, 2000. View at Google Scholar · View at Scopus
  18. M. Funke, Z. Zhao, Y. Xu, J. Chun, and A. M. Tager, “The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 46, no. 3, pp. 355–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Meng, L. Graves, T.-V. Do, J. So, and D. A. Fishman, “Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes,” Gynecologic Oncology, vol. 95, no. 3, pp. 488–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-C. Lin, C.-E. Lin, Y.-C. Lin et al., “Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 440, no. 4, pp. 564–569, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Pan, K. O'Rourke, and V. M. Dixit, “Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex,” Journal of Biological Chemistry, vol. 273, no. 10, pp. 5841–5845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zeng, T. Li, D. C. Xu et al., “Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with bax protein,” Journal of Biological Chemistry, vol. 287, no. 34, pp. 29125–29133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-Z. Cui, E. Laag, L. Sun, M. Tan, G. Zhao, and X. Xu, “Lysophosphatidic acid induces early growth response gene 1 expression in vascular smooth muscle cells: CRE and SRE mediate the transcription,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 1029–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Xu, Y.-C. Shi, W. Gao et al., “The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein,” The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48913–48922, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Dong, Y. Wu, M. Wu et al., “Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 2899–2910, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Kasof, J. J. Lu, D. Liu et al., “Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB,” Oncogene, vol. 20, no. 55, pp. 7965–7975, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Klíma, A. Broučková, M. Koc, and L. Anděra, “T-cell activation triggers death receptor-6 expression in a NF-κB and NF-AT dependent manner,” Molecular Immunology, vol. 48, no. 12-13, pp. 1439–1447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Ye, I. Ishii, M. A. Kingsbury, and J. Chun, “Lysophosphatidic acid as a novel cell survival/apoptotic factor,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, vol. 1585, no. 2-3, pp. 108–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-J. Xu, S. Ouk Kim, D.-F. Liao, S. Katz, and S. L. Pelech, “Stimulation of 90- and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysophosphatidic acid in rat cardiomyocytes,” Biochemical Pharmacology, vol. 59, no. 9, pp. 1163–1171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Shaywitz and M. E. Greenberg, “CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals,” Annual Review of Biochemistry, vol. 68, pp. 821–861, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Mizutani, S. Fukushi, M. Saijo, I. Kurane, and S. Morikawa, “Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells,” FEBS Letters, vol. 580, no. 5, pp. 1417–1424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Dubrez, I. Savoy, A. Hamman, and E. Solary, “Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways,” The EMBO Journal, vol. 15, no. 20, pp. 5504–5512, 1996. View at Google Scholar · View at Scopus
  33. Y. C. Yung, N. C. Stoddard, and J. Chun, “LPA receptor signaling: pharmacology, physiology, and pathophysiology,” Journal of Lipid Research, vol. 55, no. 7, pp. 1192–1214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Siess, K. J. Zangl, M. Essler et al., “Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 6931–6936, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Chen, X. Y. Yang, N. D. Wang et al., “Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 63, no. 7-8, pp. 497–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Benschop, T. Wei, and S. Na, “Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6,” in Therapeutic Targets of the TNF Superfamily, I. S. Grewal, Ed., pp. 186–194, Springer, New York, NY, USA, 2009. View at Google Scholar
  37. Y. Hu, X. Lee, Z. Shao et al., “A DR6/p75NTR complex is responsible for β-amyloid-induced cortical neuron death,” Cell Death & Disease, vol. 4, no. 4, article e579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Huang, X. Lee, Y. Bian et al., “Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis,” Cell Death and Disease, vol. 4, no. 10, article e841, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. F. W. Holtsberg, M. R. Steiner, A. J. Bruce-Keller et al., “Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells,” Journal of Neuroscience Research, vol. 53, no. 6, pp. 685–696, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. F. W. Holtsberg, M. R. Steiner, J. N. Keller, R. J. Mark, M. P. Mattson, and S. M. Steiner, “Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons,” Journal of Neurochemistry, vol. 70, no. 1, pp. 66–76, 1998. View at Google Scholar · View at Scopus
  41. Z.-Q. Zheng, X.-J. Fang, and J.-T. Qiao, “Dual action of lysophosphatidic acid in cultured cortical neurons: survival and apoptogenic,” Acta physiologica Sinica, vol. 56, no. 2, pp. 163–171, 2004. View at Google Scholar · View at Scopus
  42. J. O. Ban, Y.-S. Jung, D. H. Kim et al., “(E)-2,4-Bis(p-hydroxyphenyl)-2-butenal inhibits tumor growth via suppression of NF-κB and induction of death receptor 6,” Apoptosis, vol. 19, no. 1, pp. 165–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Li, M. I. Gonzalez, J. L. Meinkoth, J. Field, M. G. Kazanietz, and G. I. Tennekoon, “Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells,” The Journal of Biological Chemistry, vol. 278, no. 11, pp. 9585–9591, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Hao, F. Zhang, D. D. Wu et al., “Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61,” American Journal of Physiology—Cell Physiology, vol. 311, no. 6, pp. C975–C984, 2016. View at Publisher · View at Google Scholar